- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04678843
Adapting and Adopting Highly Specialized Pediatric Eating Disorder Treatment to Virtual Care: Implementation Research for the COVID-19 Context and Beyond (vFBT)
September 6, 2022 updated by: Jennifer Couturier
The COVID-19 pandemic has had detrimental effects on mental health.
Individuals with eating disorders (EDs) are no exception, exhibiting increased symptoms and exacerbated feelings of isolation and anxiety.
Across Canada, in-person outpatient services have been quickly replaced with virtual care, yet practitioners and patients have noted substantial challenges in adapting ED-related care virtually.
Given the success of our previous research on Family-Based Treatment (FBT) for EDs, as well as the rapid transition to virtual care during COVID-19, there is an urgent need to adapt FBT to virtual formats and adopt it in the ED network.
Using a multi-site case study with a mixed method pre/post design, this study aims to examine the implementation of virtual FBT (vFBT) as well as its impact within six ED programs in Ontario, building on the investigator's previous work, and further developing capacity in the system.
The investigator will develop implementation teams at each site and provide a virtual training workshop on vFBT, with ongoing consultation during initial implementation.
The investigator proposes to examine implementation success by studying fidelity to vFBT, as well as team and patient/family experience with virtual care, and patient outcomes.
These findings for virtual care will not only be important in the COVID-19 context but are also vital in the North, where access to specialized services is extremely limited.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
36
Phase
- Early Phase 1
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Ontario
-
Newmarket, Ontario, Canada, L3Y 2P9
- Southlake Regional Health Centre
-
Thunder Bay, Ontario, Canada, P7B 5G7
- St. Joseph's Care Group
-
Toronto, Ontario, Canada, M2J 0B1
- North York General Hospital
-
Waterloo, Ontario, Canada, N2J 4M1
- CMHA Waterloo Wellington
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
10 years to 18 years (Child, Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Youth must be under 18 years of age in order to participate
- Youth must have a diagnosis of Anorexia Nervosa in order to participate
- Must have the capacity to write, speak, and understand English
- Must have access to a computer and the internet.
Exclusion Criteria:
- Individuals 18 years of age and older are unable to participate
- Youth without a diagnosis of Anorexia Nervosa are unable to participate
- Individuals who cannot write, speak and understand English are unable to participate
- Individuals who do not have access to a computer and the internet are unable to participate
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Virtual Family-Based Treatment
Family-based treatment is the gold standard treatment for youth and adolescents with anorexia nervosa.
A therapist works with the family to help parents take charge of the process of re-feeding their child, and with progress this control is gradually given back to the youth/adolescent.
Other developmental issues are discussed in order to help the youth/adolescent get back to normal development.
|
Treatment involving the youth/adolescent who has been diagnosed with anorexia nervosa and their family, delivered virtually via videoconferencing.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Key components of FBT
Time Frame: Completed after session 4 of treatment, approximately 4 months
|
Measured by a self-report questionnaire entitled Key Measure of Therapist Behaviours and Self-Efficacy in FBT (an indicator of therapist adherence to the key components of standard FBT within the vFBT model)
|
Completed after session 4 of treatment, approximately 4 months
|
|
Fidelity
Time Frame: Completed after the session 4 of treatment, approximately 4 months
|
Fidelity to vFBT, measured by FBT fidelity ratings of the first four sessions of vFBT using the FBT Fidelity and Adherence Check (experts in FBT fidelity rating will rate the recordings).
|
Completed after the session 4 of treatment, approximately 4 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Qualitative experience of participants
Time Frame: Completed after session 4 of treatment, approximately 4 months
|
Experiences of the therapists, medical practitioners, administrators, and families in vFBT, qualitatively measured during semi-structured focus groups
|
Completed after session 4 of treatment, approximately 4 months
|
|
Change in Weight
Time Frame: At baseline before treatment, and at 1 week, 2 weeks, 3 weeks, and 4 weeks.
|
Weight will be measured in kilograms.
|
At baseline before treatment, and at 1 week, 2 weeks, 3 weeks, and 4 weeks.
|
|
Change in Number of Binge/Purge Episodes
Time Frame: At baseline before treatment, and at 1 week, 2 weeks, 3 weeks, and 4 weeks.
|
The number of binge/purge episodes each week will be recorded by patients/their families.
|
At baseline before treatment, and at 1 week, 2 weeks, 3 weeks, and 4 weeks.
|
|
Therapists' Change in Readiness
Time Frame: At baseline, after training (approx. 1 month), and after 4 sessions of treatment (approx. 4 months)
|
The Brief Individual Readiness to Change Scale will indicate how ready therapists feel they are to change.
Higher scores indicate greater readiness to use research-based direct service techniques.
Minimum score is 0, maximum score is 20.
|
At baseline, after training (approx. 1 month), and after 4 sessions of treatment (approx. 4 months)
|
|
Therapists' Change in Attitudes about Evidence Based Practice
Time Frame: At baseline, after training (approx. 1 month), and after 4 sessions of treatment (approx. 4 months)
|
Their attitudes about evidence-based practice will be assessed using the Evidence Based Practice Attitudes Scale (EBPAS).
The subscales include requirements, appeal, openness and divergence.
The score for each subscale is created by computing a mean score for the items that load on a given subscale.
Minimum score for each subscale is 0, maximum score for each subscale is 4.
|
At baseline, after training (approx. 1 month), and after 4 sessions of treatment (approx. 4 months)
|
|
Therapists' Change in Confidence related to the Intervention
Time Frame: At baseline, after training (approx. 1 month), and after 4 sessions of treatment (approx. 4 months)
|
Their confidence related to the intervention will be assessed by administering an adapted version of the Perceived Attributes of the Principles of Effectiveness Scale (MPAS).
Higher scores are indicative of more favorable perception for FBT content.
The minimum score is 18, the maximum score is 90.
|
At baseline, after training (approx. 1 month), and after 4 sessions of treatment (approx. 4 months)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Jennifer Couturier, MD MSc, McMaster University
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Couturier J, Pellegrini D, Grennan L, Nicula M, Miller C, Agar P, Webb C, Anderson K, Barwick M, Dimitropoulos G, Findlay S, Kimber M, McVey G, Paularinne R, Nelson A, DeGagne K, Bourret K, Restall S, Rosner J, Hewitt-McVicker K, Pereira J, McLeod M, Shipley C, Miller S, Boachie A, Engelberg M, Martin S, Holmes-Haronitis J, Lock J. A qualitative evaluation of team and family perceptions of family-based treatment delivered by videoconferencing (FBT-V) for adolescent Anorexia Nervosa during the COVID-19 pandemic. J Eat Disord. 2022 Jul 26;10(1):111. doi: 10.1186/s40337-022-00631-9. Erratum In: J Eat Disord. 2022 Dec 8;10(1):191.
- Couturier J, Pellegrini D, Miller C, Agar P, Webb C, Anderson K, Barwick M, Dimitropoulos G, Findlay S, Kimber M, McVey G, Lock J. Adapting and adopting highly specialized pediatric eating disorder treatment to virtual care: a protocol for an implementation study in the COVID-19 context. Implement Sci Commun. 2021 Apr 8;2(1):38. doi: 10.1186/s43058-021-00143-8.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
February 9, 2021
Primary Completion (Actual)
July 31, 2021
Study Completion (Actual)
August 1, 2021
Study Registration Dates
First Submitted
December 17, 2020
First Submitted That Met QC Criteria
December 18, 2020
First Posted (Actual)
December 22, 2020
Study Record Updates
Last Update Posted (Actual)
September 10, 2022
Last Update Submitted That Met QC Criteria
September 6, 2022
Last Verified
September 1, 2022
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 12722
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Anorexia Nervosa
-
Baylor College of MedicineEnrolling by invitationAnorexia Nervosa | Atypical Anorexia NervosaUnited States
-
Rosemary Claire RodenChildren's Miracle NetworkTerminatedBulimia Nervosa | Impulsive Behavior | Purging (Eating Disorders) | Eating Disorders | Eating Disorders in Adolescence | Anorexia Nervosa/Bulimia | Anorexia in Adolescence | Anorexia Nervosa, Atypical | Anorexia Nervosa, Binge Eating/Purging TypeUnited States
-
University of California, San DiegoActive, not recruitingAnorexia Nervosa | Bulimia Nervosa | Atypical Anorexia Nervosa | Atypical Bulimia NervosaUnited States
-
University of California, San DiegoRecruitingAnorexia Nervosa | Bulimia Nervosa | Anorexia Nervosa in RemissionUnited States
-
Fundació Institut de Recerca de l'Hospital de la...Fundació La Marató de TV3RecruitingAnorexia Nervosa | Anorexia Nervosa in Remission | Anorexia Nervosa Restricting TypeSpain
-
Duke UniversityCompletedAdolescent Anorexia Nervosa | Subthreshold Anorexia NervosaUnited States
-
Stanford UniversityNational Institute of Mental Health (NIMH); National Institutes of Health (NIH) and other collaboratorsCompletedAnorexia Nervosa | Anorexia | Eating Disorder | Eating Disorders in Adolescence | Anorexia in Adolescence | Anorexia Nervosa, Atypical | Anorexia Nervosa Restricting Type | Anorexia in ChildrenUnited States
-
Istituto Auxologico ItalianoCatholic University of the Sacred Heart; University of Turin, Italy; Open University and other collaboratorsRecruitingAnorexia Nervosa/BulimiaItaly
-
Maimónides Biomedical Research Institute of CórdobaHospital Universitario Reina Sofia de CordobaNot yet recruitingAnorexia Nervosa Restricting Type | Anorexia Nervosa (DSM-IV Revised Criteria)Spain
-
University Hospital, MontpellierCompleted
Clinical Trials on Virtual Family-Based Treatment
-
Mayo ClinicNational Institute of Mental Health (NIMH)Enrolling by invitationEating DisordersUnited States
-
Inova Health Care ServicesCompletedChildhood Obesity | Health Behavior | Diet, HealthyUnited States
-
Helsinki University Central HospitalCompletedEating Disorders
-
Mayo ClinicCompletedMood Disorders in Children and AdolescentsUnited States
-
New York State Psychiatric InstituteCompletedAnorexia Nervosa
-
University of PittsburghNational Institutes of Health (NIH)CompletedBehavior
-
Stanford UniversityUniversity of ChicagoCompleted
-
Stanford UniversityNational Institute of Mental Health (NIMH); National Institutes of Health (NIH) and other collaboratorsCompletedAnorexia Nervosa | Anorexia | Eating Disorder | Eating Disorders in Adolescence | Anorexia in Adolescence | Anorexia Nervosa, Atypical | Anorexia Nervosa Restricting Type | Anorexia in ChildrenUnited States
-
Stanford UniversityMcMaster UniversityCompletedAnorexia NervosaUnited States, Canada
-
University of PittsburghNational Institute of Mental Health (NIMH); Lifespan; Rhode Island CollegeCompletedAnorexia Nervosa | Eating DisordersUnited States